Giuseppe Caramanno

Showing 1-6 of 6 articles

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabaté M, Tamburino C, Nef H, Gori T

October 11, 2017 | 10.4244/EIJ-D-16-00568

Coronary interventions

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S

April 20, 2017 | 10.4244/EIJ-D-16-00974

Coronary interventions

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras S, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabaté M, Mattesini A, Geraci S, Naber C, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T

August 5, 2016 | 10.4244/EIJY15M09_10

Coronary interventions

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience

Ielasi A, Miyazaki T, Geraci S, Testa L, Abdel-Wahab M, Kawamoto H, Ruparelia N, Sato T, Caramanno G, Bedogni F, Tespili M, Colombo A, Latib A

April 8, 2016 | 10.4244/EIJV11I14A309

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective

Tamburino C, Latib A, van Geuns R, Sabaté M, Mehilli J, Gori T, Achenbach S, Alvarez M, Nef H, Lesiak M, Di Mario C, Colombo A, Naber C, Caramanno G, Capranzano P, Brugaletta S, Geraci S, Araszkiewicz A, Mattesini A, Pyxaras S, Rzeszutko L, Depukat R, Diletti R, Boone E, Capodanno D, Dudek D

May 19, 2015 | 10.4244/EIJY15M01_05

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C

February 20, 2015 | 10.4244/EIJY14M07_11

1

Latest news

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

January 20, 2021

The Year in Review

January 22, 2021

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Moving (re-shaping) the mitral annulus

January 20, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Use of intravascular OCT or IVUS to guide stent implantation.

January 20, 2021

Last Week's JAA's: TTVr with the TriClip/MitraClip G4 System and much more...

January 12, 2021

Valvular disease